Home Infusion for Crohn's Disease: Remicade, Biologics, and What Patients Should Know

April 23, 2026

For many patients with moderate-to-severe Crohn's disease, biologic therapies delivered by IV infusion , most commonly Remicade (infliximab) , are a cornerstone of long-term disease management. Receiving these infusions through home infusion therapy is an option for many stable patients, sparing them repeated trips to an infusion center. Pharmko coordinates this care across 23 states.


How Remicade (Infliximab) Works for Crohn's Disease


Remicade is a monoclonal antibody that targets tumor necrosis factor-alpha (TNF-α), a protein central to the inflammatory response in Crohn's disease. By neutralizing TNF-α, it reduces intestinal inflammation, helps heal the lining of the bowel, and can achieve and maintain clinical remission in patients who have not responded to conventional therapies.


It is given on a schedule determined by your gastroenterologist , typically at weeks 0, 2, and 6 for induction, followed by maintenance infusions every 8 weeks. For a broader comparison of home infusion approaches vs. clinical settings, see our safety guide.


Other IV Biologics Used in Crohn's Disease


While Remicade is most commonly prescribed, others may be used depending on the patient's disease course:


  • Entyvio (vedolizumab) , targets gut-specific integrin receptors, with a favorable long-term safety profile
  • Tysabri (natalizumab) , used in select cases when other therapies have failed


Your gastroenterologist will determine which biologic is most appropriate for your situation.


Can You Receive Remicade Infusions at Home?


Yes, for many patients. Home infusion of Remicade and other IV biologics is well established, though it requires a few prerequisites: the patient must have received at least their first one to three infusions in a supervised clinical setting to screen for reactions, and must be on a stable maintenance dose.


For patients transitioning from hospital-based infusions, our hospital-to-home transition guide covers what to expect during the changeover and what Pharmko handles on your behalf.


What a Home Remicade Infusion Looks Like


Before the infusion


A Pharmko nurse reviews your current medications, confirms you have no active infections, and takes baseline vital signs. Pre-medications may be administered per your physician's orders to reduce the risk of infusion reactions.


During the infusion


The infusion runs over approximately 2 hours. Your nurse monitors your vital signs at regular intervals and is present to respond immediately if you experience any discomfort or reaction.


After the infusion


Your nurse documents the session and communicates with your gastroenterologist's office. Review which symptoms to watch for in the hours and days following the infusion , and save the number for our 24/7 after-hours support team before your first dose.


Insurance Coverage for Home Remicade Infusions


Remicade is covered by most commercial insurance plans and Medicare Part B under a medical benefit when administered by a licensed provider. Prior authorization is required. Pharmko handles the authorization process and will notify you of any coverage concerns before your first home infusion.


Contact Pharmko to start a referral: 1-877-549-3863

How to Choose a Home Infusion Pharmacy
June 26, 2026
Not all home infusion pharmacies are equal. Learn the 7 key questions to ask before choosing a specialty pharmacy, accreditation, clinical support, state licensing, and more.
Home Infusion for Lupus: Benlysta and Biologic Therapy Options for SLE
June 25, 2026
Learn how home infusion therapy works for lupus (SLE), including Benlysta (belimumab) and other IV biologics, who qualifies for home treatment, and how Pharmko supports ongoing lupus care across 22+ states.
IPN Therapy for Peritoneal Dialysis Patients
June 25, 2026
Learn how intraperitoneal nutrition (IPN) works for malnourished peritoneal dialysis patients, who qualifies, how amino acids are delivered during PD exchanges, and how Pharmko coordinates IPN therapy.
Home Infusion Therapy in New York
June 17, 2026
Pharmko is based in New York and provides home infusion therapy statewide — IV antibiotics, IVIG, TPN, IDPN, and specialty medications. Licensed, ACHC accredited, and available 24/7.
Home Infusion for Osteomyelitis
June 15, 2026
Osteomyelitis requires weeks of IV antibiotics that can often be completed at home. Learn who qualifies for OPAT, what the treatment timeline looks like, and how Pharmko supports bone infection recovery.
What Is a PICC Line
June 15, 2026
Learn what a PICC line is, how it's inserted, how to care for it at home, and why it's the most common IV access device for home infusion therapy. Pharmko nurses provide full PICC line training.
IV Iron Infusion at Home: Feraheme, Injectafer, and Iron Deficiency Anemia Treatment
June 12, 2026
Learn how IV iron infusion works at home — which products are used, who qualifies, what to expect during treatment, and how Pharmko delivers iron infusion therapy across 22+ states.
Home Infusion for Multiple Sclerosis
June 11, 2026
Learn how home infusion therapy works for multiple sclerosis, including Ocrevus and Tysabri, who qualifies for home-based MS infusions, what to expect, and how Pharmko coordinates care.
TPN at Home: Who Qualifies, How It Works, and What to Expect
June 11, 2026
Learn how total parenteral nutrition (TPN) at home works — who qualifies, how it's delivered, what daily life looks like, and how Pharmko supports patients from first dose through long-term therapy.
Low Albumin in Dialysis Patients
June 3, 2026
Low albumin is a key marker of malnutrition in dialysis patients. Learn what causes albumin decline, when IDPN is indicated, and how Pharmko supports renal nutrition across 22+ states.
Show More